JOHNSON & JOHNSON |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.56 CAD | +0.15% |
|
-1.95% | -7.52% |
| 06-28 | Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial | MT |
| 06-28 | J&J Unit's Rybrevant Combo Gets EU Approval | MT |
c4e57d7.ZozhHkh-p7VHg3xlQ55LZOLdPV3PBYmtxI5yQLjd68c.Cvm7SCUs0tImtlELIc8zKaS6Vwq3cf75pbogBPyZivEC6NdvCRfV5A_TLQ~7eb5d10354461c190c73cb73df789119
